查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1448481

再生醫學市場：趨勢、預測、競爭分析

Regenerative Medicine Market: Trends, Forecast and Competitive Analysis
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

再生醫學市場趨勢及預測

預計到 2030 年，全球再生醫學市場將達到 102 億美元，2024 年至 2030 年年複合成長率預計為 3.0%。該市場的關鍵促進因素是人們對個人化醫療的日益偏好、政府和私人機構對研發活動的投資增加以及幹細胞治療的技術進步。全球再生醫學市場的未來前景廣闊，在肌肉骨骼疾病、傷口護理、腫瘤學、眼科疾病和糖尿病領域都有機遇。

再生醫學市場新趨勢

對產業動態產生直接影響的新興趨勢包括更多地採用幹細胞技術以及更多地在組織工程和再生醫學中使用 3D 生物列印技術。

在這個市場中，基於細胞的免疫和細胞療法是最大的再生醫學產品，肌肉骨骼疾病是最大的應用領域。再生醫學市場各細分領域的成長情況如下圖所示：

本研究按材料、產品、應用、分銷管道和地區總結了全球再生醫學市場的趨勢和預測如下：

依材料分類[2018-2030年金額（百萬美元）出貨量分析]：

  • 合成
    • 鷹架材料
    • 人工血管移植材料
    • 水凝膠材料
  • 生物來源材料
    • 膠原蛋白
    • 不同材料
  • 基因改造材料
    • 去氧核糖核酸轉染載體
    • 基因工程細胞
    • 3D聚合物技術
    • 基因改造的
    • 纖維母細胞
    • 神經幹細胞
    • 基因活化矩陣
  • 藥品
    • 小分子藥物
    • 生技藥品

依產品[2018-2030年金額（百萬美元）出貨量分析]：

  • 基於細胞的免疫治療/細胞治療產品
  • 組織工程產品
  • 小分子/生技藥品
  • 基因治療產品

依應用分【2018年至2030年出貨收益分析（百萬美元）】：肌肉骨骼疾病

  • 肌肉骨骼疾病
  • 傷口護理
  • 腫瘤學
  • 眼科疾病
  • 糖尿病
  • 其他

依分銷管道分類[2018-2030年金額（百萬美元）出貨量分析]

  • 醫院
  • 診所
  • 其他

依地區分類【2018-2030年出貨收益分析（百萬美元）】：北美

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
  • 亞太地區
    • 中國
    • 印度
    • 日本
  • 其他
    • 巴西

再生醫學市場洞察

  • Lucintel 預計，由於政府加強對細胞治療產品研發活動的支持，以及 FDA 頒布《治癒法案》以核准再生醫學核准，基於細胞的免疫學和細胞治療產品將成為預測期內最大的細分市場。預計這種情況將持續下去。
  • 在這個市場中，由於整形外科疾病的增加和老年人口的成長，預計肌肉骨骼疾病在預測期內仍將是最大的應用領域。
  • 由於先進技術的存在以及大量研究機構參與開發新療法，預計北美在預測期內仍將是最大的地區。

常問問題

Q1.市場規模為：

答：預計到2030年，全球再生醫學市場將達到102億美元。

Q2.市場成長預測是多少：

答：2024年至2030年，再生醫學市場預計年複合成長率為3.0%。

Q3.影響市場成長的關鍵促進因素是：

A1. 該市場的關鍵促進因素是人們對個人化醫療的日益偏好、政府和私人機構對研發活動的投資增加以及幹細胞治療的技術進步。

Q4.再生醫學的主要最終用途是什麼？

答：醫院和診所是再生醫學的主要最終用途。

Q5.再生醫學市場有哪些新趨勢？

答：對產業動態有直接影響的新興趨勢包括幹細胞技術的更多採用以及組織工程和再生醫學中 3D 生物列印技術的更多使用。

Q6. 主要的再生醫學公司有哪些？

答：主要的再生醫學公司有：

  • Kite Pharma
  • Novartis
  • Vericel
  • Integra LifeSciences
  • Wright Medical
  • MiMedx
  • Osiris Therapeutics
  • Stryker
  • Spark Therapeutics
  • Zimmer Biomet

Q7. 未來再生醫學原料領域哪個領域成長最快？

A4.Lucintel 預計，由於政府加強對細胞治療產品相關研發活動的支持，以及 FDA 簡化再生醫學核准的治癒法案的頒布，基於細胞的免疫和細胞治療產品將在預期期間繼續成長。仍然是世界上最大的細分市場。

Q8：未來五年哪個地區的再生醫學市場最大？

答：未來五年，北美仍將是最大的。

Q9. 可以客製化報告嗎？

答：是的，Lucintel 列出了 10% 的客製化服務，無需額外費用。

目錄

第2章 市場背景及分類

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢和預測
  • 全球再生醫學市場趨勢及預測
  • 按材料分類的全球再生醫學市場
    • 合成
      • 鷹架
      • 人造血管材料
      • 水凝膠材料
    • 生物來源材料
      • 膠原蛋白
      • 不同材料
    • 基因改造材料
      • 去氧核糖核酸轉染載體
      • 基因工程細胞
      • 3D聚合物技術
      • 基因改造技術
      • 纖維母細胞
      • 神經幹細胞
      • 基因活化矩陣
    • 藥品
      • 低分子
      • 生技藥品
  • 全球再生醫學市場按產品分類
    • 基於細胞的免疫療法和細胞治療產品
    • 組織工程產品
    • 小分子和生技藥品
    • 基因治療產品
  • 全球再生醫學市場的應用
    • 肌肉骨骼疾病
    • 創傷護理
    • 腫瘤學
    • 眼科疾病
    • 糖尿病
    • 其他
  • 按分銷管道分類的全球再生醫學市場
    • 醫院
    • 診所
    • 其他

第4章 區域市場趨勢及預測分析

  • 全球再生醫學市場按地區分類
  • 北美再生醫學市場
  • 歐洲再生醫學市場
  • 亞太再生醫學市場
  • 其他地區再生醫學市場

第5章 競爭分析

  • 市場佔有率分析
  • 產品系列分析
  • 營運整合
  • 地理範圍
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球再生醫學市場按材料的成長機會
    • 全球再生醫學市場成長機會（按產品）
    • 全球再生醫學市場成長機會（按應用）
    • 按分銷管道分類的全球再生醫學市場成長機會
    • 全球再生醫學市場成長機會（按地區）
  • 全球再生醫學市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球再生醫學市場容量
    • 全球再生醫學市場的合併、收購與合資

第7章主要企業概況

  • Kite Pharma
  • Novartis
  • Vericel Corporation
  • Integra LifeSciences
  • Wright Medical
  • MiMedx
  • Osiris Therapeutics
  • Stryker Corporation
  • Spark Therapeutics
  • Zimmer Biomet Holdings, Inc.
簡介目錄

Regenerative Medicine Market Trends and Forecast

The future of the global regenerative medicine market looks promising with opportunities in musculoskeletal disorders, wound care, oncology, ocular disorders, and diabetes. The global regenerative medicine market is expected to reach an estimated $10.2 billion by 2030, and it is forecast to grow at a CAGR of 3.0% from 2024 to 2030. The major drivers for this market are increasing preference of people for personalized medicines, rising investment by governments and private agencies regarding research and development activities, and technological advancements in stem-cell therapies.

Emerging Trends in the Regenerative Medicine Market

Emerging trends, which have a direct impact on the dynamics of the industry, include increasing adoption of stem cell technologies and increasing use of 3D bioprinting technologies in tissue engineering & regenerative medicine.

A total of 94 figures / charts and 87 tables are provided in this more than 184-page report to help in your business decisions. Sample figures with some insights are shown below.

In this market, cell-based immunology & cell therapy is the largest product of regenerative medicine, whereas musculoskeletal disorders is the largest application. Growth in various segments of the regenerative medicine market are given below:

The study includes trends and forecast for the global regenerative medicine market by material, product, application, distribution channel, and region as follows:

By Material [Value ($ Million) shipment analysis for 2018 - 2030]:

  • Synthetic
    • Scaffold
    • Artificial Vascular Graft Materials
    • Hydrogel Materials
  • Biologically Derived Materials
    • Collagen
    • Xenogeneic Materials
  • Genetically Engineered Materials
    • Deoxyribonucleic Acid Transfection Vectors
    • Genetically Manipulated Cells
    • Three-Dimensional Polymer Technology
    • Transgenics
    • Fibroblasts
    • Neural Stem Cells
    • Gene-Activated Matrices
  • Pharmaceuticals
    • Small Molecules
    • Biologics

By Product [Value ($ Million) shipment analysis for 2018 - 2030]:

  • Cell-Based Immunotherapy & Cell Therapy Products
  • Tissue-Engineered Products
  • Small Molecules and Biologics
  • Gene Therapy Products

By Application [Value ($ Million) shipment analysis for 2018 - 2030]:

  • Musculoskeletal Disorders
  • Wound Care
  • Oncology
  • Ocular Disorders
  • Diabetes
  • Other Applications

By Distribution Channel [Value ($ Million) shipment analysis for 2018 - 2030]:

  • Hospitals
  • Clinics
  • Others

By Region [Value ($ Million) shipment analysis for 2018 - 2030]:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
  • The Rest of the World
    • Brazil

List of Regenerative Medicine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies regenerative medicine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the regenerative medicine companies profiled in this report include.

  • Kite Pharma
  • Novartis
  • Vericel
  • Integra LifeSciences
  • Wright Medical
  • MiMedx
  • Osiris Therapeutics
  • Stryker
  • Spark Therapeutics
  • Zimmer Biomet

Regenerative Medicine Market Insights

  • Lucintel forecasts that cell-based immunology and cell therapy products will remain the largest segment over the forecast period due to increasing government support in research and development activities related to cell therapy products and establishment of the Cures Act by FDA for streamlining the approval of regenerative medicine.
  • Within this market, musculoskeletal disorders will remain the largest segment by application over the forecast period due to increasing orthopedic diseases and rising geriatric population.
  • North America will remain the largest region over the forecast period due to presence of advanced technologies and a large number of research institutes involved in the development of novel therapeutics.

Features of the Regenerative Medicine Market

  • Market Size Estimates: Regenerative medicine market size estimation in terms of value ($M).
  • Trend and Forecast Analysis: Market trends (2018-2023) and forecast (2024-2030) by various segments and regions.
  • Segmentation Analysis: Regenerative medicine market size by various segments, such as material, product, application, and distribution channel.
  • Regional Analysis: Regenerative medicine market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth Opportunities: Analysis on growth opportunities in different material, product, application, distribution channel, and regions for regenerative medicine market.
  • Strategic Analysis: This includes M&A and competitive landscape for the regenerative medicine .
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the regenerative medicine market size?

Answer:The global regenerative medicine market is expected to reach an estimated $10.2 billion by 2030.

Q2. What is the growth forecast for regenerative medicine market?

Answer:The regenerative medicine market is expected to grow at a CAGR of 3.0% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the regenerative medicine market?

Answer: The major drivers for this market are increasing preference of people for personalized medicines, rising investment by governments and private agencies regarding research and development activities, and technological advancements in stem-cell therapies.

Q4. What are the major applications or end use industries for regenerative medicine?

Answer:Hospital and clinic are the major end uses for regenerative medicine

Q5. What are the emerging trends in regenerative medicine market?

Answer:Emerging trends, which have a direct impact on the dynamics of the industry, include increasing adoption of stem cell technologies and increasing use of 3D bioprinting technologies in tissue engineering & regenerative medicine.

Q6. Who are the key regenerative medicine companies?

Answer:Some of the key regenerative medicine companies are as follows:

  • Kite Pharma
  • Novartis
  • Vericel
  • Integra LifeSciences
  • Wright Medical
  • MiMedx
  • Osiris Therapeutics
  • Stryker
  • Spark Therapeutics
  • Zimmer Biomet

Q7.Which regenerative medicine raw material segment will be the largest in future?

Answer: Lucintel forecasts that cell-based immunology and cell therapy products will remain the largest segment over the forecast period due to increasing government support in research and development activities related to cell therapy products and establishment of the Cures Act by FDA for streamlining the approval of regenerative medicine.

Q8: In regenerative medicine market, which region is expected to be the largest in next 5 years?

Answer:North America will remain the largest region in next 5 years.

Q9. Do we receive customization in this report?

Answer:Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions

  • Q.1 What are some of the most promising potential, high-growth opportunities for the global regenerative medicine market by material (synthetic (scaffold, artificial vascular graft materials, and hydrogel materials), biologically derived materials (collagen and xenogeneic materials), genetically engineered materials (deoxyribonucleic acid transfection vectors, genetically manipulated cells, three-dimensional polymer technology, transgenics, fibroblasts, neural stem cells, and gene-activated matrices), and pharmaceuticals (small molecules and biologics)), product (cell-based immunotherapy & cell therapy products, tissue-engineered products, small molecules and biologics, and gene therapy products), application (musculoskeletal disorders, wound care, oncology, ocular disorders, diabetes, and other applications), distribution channel (hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
  • Q. 2 Which segments will grow at a faster pace and why?
  • Q.3 Which region will grow at a faster pace and why?
  • Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the market?
  • Q.5 What are the business risks and threats to the market?
  • Q.6 What are the emerging trends in this market and the reasons behind them?
  • Q.7 What are some changing demands of customers in the market?
  • Q.8 What are the new developments in the market? Which companies are leading these developments?
  • Q.9 Who are the major players in this market? What strategic initiatives are being implemented by key players for business growth?
  • Q.10 What are some of the competitive products and processes in this market, and how big of a threat do they pose for loss of market share via material or product substitution?
  • Q.11 What M & A activities did take place in the last five years in this market?

Table of Contents

2. Market Background and Classifications

  • 2.1 Introduction, Background, and Classifications
  • 2.2 Supply Chain
  • 2.3 Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1 Macroeconomic Trends and Forecast
  • 3.2 Global Regenerative Medicine Market Trends and Forecast
  • 3.3 Global Regenerative Medicine Market by Material
    • 3.3.1 Synthetic
      • 3.3.1.1 Scaffold
      • 3.3.1.2 Artificial Vascular Graft Materials
      • 3.3.1.3 Hydrogel Materials
    • 3.3.2 Biologically Derived Materials
      • 3.3.2.1 Collagen
      • 3.3.2.2 Xenogeneic Materials
    • 3.3.3 Genetically Engineered Materials
      • 3.3.3.1 Deoxyribonucleic Acid Transfection Vectors
      • 3.3.3.2 Genetically Manipulated Cells
      • 3.3.3.3 Three-dimensional Polymer Technology
      • 3.3.3.4 Transgenics
      • 3.3.3.5 Fibroblasts
      • 3.3.3.6 Neural Stem Cells
      • 3.3.3.7 Gene-activated Matrices
    • 3.3.4 Pharmaceuticals
      • 3.3.4.1 Small Molecules
      • 3.3.4.2 Biologics
  • 3.4 Global Regenerative Medicine Market by Product
    • 3.4.1 Cell-Based Immunotherapy & Cell Therapy Products
    • 3.4.2 Tissue-Engineered Products
    • 3.4.3 Small Molecules And Biologics
    • 3.4.4 Gene Therapy Products
  • 3.5 Global Regenerative Medicine Market by Application
    • 3.5.1 Musculoskeletal Disorders
    • 3.5.2 Wound Care
    • 3.5.3 Oncology
    • 3.5.4 Ocular Disorders
    • 3.5.5 Diabetes
    • 3.5.6 Other Applications
  • 3.6 Global Regenerative Medicine Market by Distribution Channel
    • 3.6.1 Hospitals
    • 3.6.2 Clinic
    • 3.6.3 Others

4. Market Trends and Forecast Analysis by Region

  • 4.1 Global Regenerative Medicine Market by Region
  • 4.2 North American Regenerative Medicine Market
    • 4.2.1 Market by Material: Synthetic (Scaffold, Artificial Vascular Graft Materials, and Hydrogel Materials), Biologically Derived Materials (Collagen and Xenogeneic Materials), Genetically Engineered Materials (Deoxyribonucleic Acid Transfection Vectors, Genetically Manipulated Cells, Three-dimensional Polymer Technology, Transgenics, Fibroblasts, Neural Stem Cells, and Gene-activated Matrices), Pharmaceuticals (Small Molecules and Biologics)
    • 4.2.2 Market by Product: Cell-Based Immunotherapy & Cell Therapy Products, Tissue-Engineered Products, Small Molecules and Biologics, and Gene Therapy Products
    • 4.2.3 Market by Application: Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, and Other Applications
    • 4.2.4 Market by Distribution Channel: Hospitals, Clinics, and Others
    • 4.2.5 The United States Regenerative Medicine Market
    • 4.2.6 The Canadian Regenerative Medicine Market
    • 4.2.7 The Mexican Regenerative Medicine Market
  • 4.3 European Regenerative Medicine Market
    • 4.3.1 Market by Material: Synthetic (Scaffold, Artificial Vascular Graft Materials, and Hydrogel Materials), Biologically Derived Materials (Collagen and Xenogeneic Materials), Genetically Engineered Materials (Deoxyribonucleic Acid Transfection Vectors, Genetically Manipulated Cells, Three-dimensional Polymer Technology, Transgenics, Fibroblasts, Neural Stem Cells, and Gene-activated Matrices), Pharmaceuticals (Small Molecules and Biologics)
    • 4.3.2 Market by Product: Cell-Based Immunotherapy & Cell Therapy Products, Tissue-Engineered Products, Small Molecules and Biologics, and Gene Therapy Products
    • 4.3.3 Market by Application: Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, and Other Applications
    • 4.3.4 Market by Distribution Channel: Hospitals, Clinics, and Others
    • 4.3.5 The Regenerative Medicine Market of the United Kingdom
    • 4.3.6 The German Regenerative Medicine Market
    • 4.3.7 The French Regenerative Medicine Market
  • 4.4 APAC Regenerative Medicine Market
    • 4.4.1 Market by Material: Synthetic (Scaffold, Artificial Vascular Graft Materials, and Hydrogel Materials), Biologically Derived Materials (Collagen and Xenogeneic Materials), Genetically Engineered Materials (Deoxyribonucleic Acid Transfection Vectors, Genetically Manipulated Cells, Three-dimensional Polymer Technology, Transgenics, Fibroblasts, Neural Stem Cells, and Gene-activated Matrices), Pharmaceuticals (Small Molecules and Biologics)
    • 4.4.2 Market by Product: Cell-Based Immunotherapy & Cell Therapy Products, Tissue-Engineered Products, Small Molecules and Biologics, and Gene Therapy Products
    • 4.4.3 Market by Application: Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, and Other Applications
    • 4.4.4 Market by Distribution Channel: Hospitals, Clinics, and Others
    • 4.4.5 The Chinese Regenerative Medicine Market
    • 4.4.6 The Indian Regenerative Medicine Market
    • 4.4.7 The Japanese Regenerative Medicine Market
  • 4.5 ROW Regenerative Medicine Market
    • 4.5.1 Market by Material: Synthetic (Scaffold, Artificial Vascular Graft Materials, and Hydrogel Materials), Biologically Derived Materials (Collagen and Xenogeneic Materials), Genetically Engineered Materials (Deoxyribonucleic Acid Transfection Vectors, Genetically Manipulated Cells, Three-dimensional Polymer Technology, Transgenics, Fibroblasts, Neural Stem Cells, and Gene-activated Matrices), Pharmaceuticals (Small Molecules and Biologics)
    • 4.5.2 Market by Product: Cell-Based Immunotherapy & Cell Therapy Products, Tissue-Engineered Products, Small Molecules and Biologics, and Gene Therapy Products
    • 4.5.3 Market by Application: Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, and Other Applications
    • 4.5.4 Market by Distribution Channel: Hospitals, Clinics, and Others
    • 4.5.5 Brazilian Regenerative Medicine Market

5. Competitor Analysis

  • 5.1 Market Share Analysis
  • 5.2 Product Portfolio Analysis
  • 5.3 Operational Integration
  • 5.4 Geographical Reach
  • 5.5 Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1 Growth Opportunity Analysis
    • 6.1.1 Growth Opportunities for the Global Regenerative Medicine Market by Material
    • 6.1.2 Growth Opportunities for the Global Regenerative Medicine Market by Product
    • 6.1.3 Growth Opportunities for the Global Regenerative Medicine Market by Application
    • 6.1.4 Growth Opportunities for the Global Regenerative Medicine Market by Distribution Channel
    • 6.1.5 Growth Opportunities for the Global Regenerative Medicine Market by Region
  • 6.2 Emerging Trends in the Global Regenerative Medicine Market
  • 6.3 Strategic Analysis
    • 6.3.1 New Product Development
    • 6.3.2 Capacity Expansion of the Global Regenerative Medicine Market
    • 6.3.3 Mergers, Acquisitions, and Joint Ventures in the Global Regenerative Medicine Market

7. Company Profiles of Leading Players

  • 7.1 Kite Pharma
  • 7.2 Novartis
  • 7.3 Vericel Corporation
  • 7.4 Integra LifeSciences
  • 7.5 Wright Medical
  • 7.6 MiMedx
  • 7.7 Osiris Therapeutics
  • 7.8 Stryker Corporation
  • 7.9 Spark Therapeutics
  • 7.10 Zimmer Biomet Holdings, Inc.